Apimeds Pharmaceuticals U...

NYSE: APUS · Real-Time Price · USD
1.76
-0.14 (-7.37%)
At close: Aug 20, 2025, 11:53 AM

Apimeds Pharmaceuticals US Inc Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-1.39M -777.69K -668.67K -1.03M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
n/a 69.99K 193.54K 193.54K
Other Working Capital
538.75K 41.84K -2.18K 2.84K
Other Non-Cash Items
117.72K 38.07K 29.14K 6.74K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
538.75K 41.84K -2.18K 2.84K
Operating Cash Flow
-733.53K -627.79K -448.17K -823.11K
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
250K n/a 260K 400K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
76.5K -22.9K 22.9K n/a
Financial Cash Flow
326.5K 1.03M 282.9K 400K
Net Cash Flow
-407.03K 404.31K -165.27K -423.11K
Free Cash Flow
-733.53K -627.79K -448.17K -823.11K